
Weighing the benefits and trade-offs of preserved versus preservative-free glaucoma treatments is key to optimizing long-term patient care.
Mildred M.G. Olivier, MD, is an associate dean for Ponce’s Regional Campus in Saint Louis, Missouri, and professor of ophthalmology at Ponce and Saint Louis University.
Weighing the benefits and trade-offs of preserved versus preservative-free glaucoma treatments is key to optimizing long-term patient care.